Skip to main content

Tenaya Therapeutics, Inc. (TNYA)

NASDAQ: TNYA · Delayed Price · USD
20.32 0.89 (4.58%)
Sep 21, 2021 4:00 PM EDT - Market closed
Market Cap799.08M
Revenue (ttm)n/a
Net Income (ttm)-42.44M
Shares Out39.32M
EPS (ttm)-1.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume167,118
Open19.77
Previous Close19.43
Day's Range18.69 - 20.58
52-Week Range15.35 - 28.72
Betan/a
Analystsn/a
Price Target36.00 (+77.2%)
Est. Earnings DateNov 10, 2021

About TNYA

Tenaya Therapeutics is a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease. We are advancing a pipeline of disease-modifying therapies developed using our product platforms and core internal capabilities to target defined sub-populations of patients with both rare and highly prevalent forms of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and University of Texas Southwestern Medical Center, we are dev...

IndustryBiotechnology
IPO DateJul 30, 2021
CEOFaraz Ali, M.B.A.
Employees85
Stock ExchangeNASDAQ
Ticker SymbolTNYA
Full Company Profile

Financial Performance

Financial Statements

News

Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $TNYA--Tenaya Therapeutics reported business and program updates and second quarter 2021 financial results.

1 week ago - Business Wire

Tenaya Therapeutics to Present at Morgan Stanley 19th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $TNYA--Tenaya Therapeutics announced that it will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference.

3 weeks ago - Business Wire

Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters' Op...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tenaya Therapeutics, Inc. announced today the closing of its underwritten, upsized initial public offering.

1 month ago - Business Wire

Tenaya Therapeutics Announces Pricing of Upsized Initial Public Offering

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced today ...

1 month ago - Business Wire

2 more biotech companies, backed by industry pioneers, plot IPOs

One company was launched by the venture capital firm led by Genentech's first scientist; the other by an inventor of an early defibrillator.

2 months ago - San Francisco Business Times

Tenaya Therapeutics IPO Registration Document (S-1)

Tenaya Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC